Prot#TRACT-CD-201: A Phase IB Study to Investigate the Safety, Tolerability and Efficacy of T Regulatory Cells for the Treatment of Moderate to Severe Active Crohn's Disease Refractory to Conventional and/or Biological Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date6/25/216/25/24

Funding

  • TRACT Therapeutics, Inc. (TRACT-CD-201)